Overall it seems like a very promising alternative offering similar results to Wegovy with a similar side effect profile to current GLP-1 RA weight medications, said Garcia-Webb
The connection between Ozempic and gallbladder problems, along with the impact on gastrointestinal function, underscores the importance of understanding the risks associated with this medication
They require prior authorization before Medicaid covers Wegovy
Constipation: Occurs in 3% to 5% of patients, compared to 1.5% on a placebo
Despite that the serious adverse events (SAE) were similar to semaglutide 1 mg, the AE leading to drug discontinuation were 1030% compared to 4% with semaglutide 1 mg (Table 3)
According to the ranks of the predictors (contaminants), deoxynivalenol (DON) and Bisphenol S were the top linear predictors of cord serum metabolites and clusters PC2 and PC11 (Fig